These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2548127)

  • 41. Loss of striatal mu1 opiate binding by substantia nigra lesions in the rat.
    Bodnar RJ; Clark JA; Cooper ML; Pasternak GW
    Life Sci; 1988; 43(21):1697-700. PubMed ID: 2848168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation.
    Churchill L; Kalivas PW
    Synapse; 1992 May; 11(1):47-57. PubMed ID: 1318584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biological activity of mu opioid receptor.
    Roy S; Loh HH
    Neuropharmacology; 1987 Jul; 26(7B):917-21. PubMed ID: 2821434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatment.
    Selley DE; Nestler EJ; Breivogel CS; Childers SR
    Brain Res; 1997 Jan; 746(1-2):10-8. PubMed ID: 9037478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Molecular pharmacology of opioid receptor mechanisms].
    Ueda H
    Nihon Yakurigaku Zasshi; 1989 Dec; 94(6):339-49. PubMed ID: 2558062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
    Yabaluri N; Medzihradsky F
    Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [3H]ohmefentanyl preferentially binds to mu-opioid receptors but also labels sigma-sites in rat brain sections.
    Wang H; Pélaprat D; Roques BP; Vanhove A; Chi ZQ; Rostène W
    Eur J Pharmacol; 1991 Feb; 193(3):341-50. PubMed ID: 1647320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics of mu and delta opioid binding sites in striatal slices of morphine-tolerant and -dependent mice.
    Abdelhamid EE; Takemori AE
    Eur J Pharmacol; 1991 Jun; 198(2-3):157-63. PubMed ID: 1650700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beta-adrenoceptor-sensitive adenylate cyclase is inhibited by activation of mu-opioid receptors in rat striatal neurons.
    Van Vliet BJ; Ruuls SR; Drukarch B; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1991 Mar; 195(2):295-300. PubMed ID: 1651867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.
    Wang WW; Shahrestanifar M; Jin J; Howells RD
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12436-40. PubMed ID: 8618916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mu and delta receptors belong to a family of receptors that are coupled to potassium channels.
    North RA; Williams JT; Surprenant A; Christie MJ
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5487-91. PubMed ID: 2440052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effect of mu, delta, and kappa ligands on G protein alpha subunits in cultured brain cells.
    Vogel Z; Barg J; Attali B; Simantov R
    J Neurosci Res; 1990 Sep; 27(1):106-11. PubMed ID: 2174976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
    Onali P; Olianas MC
    Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes.
    Breivogel CS; Selley DE; Childers SR
    J Neurochem; 1997 Apr; 68(4):1462-72. PubMed ID: 9084416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced affinity of mu-opioid receptors in morphine-dependent mice.
    Abdelhamid EE; Takemori AE
    Prog Clin Biol Res; 1990; 328():523-6. PubMed ID: 2154814
    [No Abstract]   [Full Text] [Related]  

  • 59. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA; Lutz RA; Munson PJ; Rodbard D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.